Halozyme reports fourth quarter and full-year 2017 results
Halozyme reported net income for the 2017 fourth quarter was $123.9 million, or $0.85 per share, versus a net loss in the 2016 fourth quarter of $27.4 million, or $0.21 per share. Revenue for the 2017 fourth quarter was $189.6 million versus $39 million for the same 2016 quarter. February 20, 2018